Report Detail

Medical Industry Global 3D Printing Technology in Pharmaceutical Market Research Report 2022

  • RnM4442034
  • |
  • 23 May, 2022
  • |
  • Global
  • |
  • 85 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Summary:

The traditional pharmaceutical process is complicated, while the 3D printing of drugs has the characteristics of "rapid prototyping" and the production process is simple. And the production equipment required for 3D printing drugs is much smaller than traditional pharmaceutical equipment, which can realize on-demand production, which has significant advantages in large-scale and small-scale drug production.
Industry Insights
Due to the COVID-19 pandemic, the global 3D Printing Technology in Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe 3D Printing Technology in Pharmaceutical market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe 3D Printing Technology in Pharmaceutical landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Material Extrusion accounting for % of the 3D Printing Technology in Pharmaceutical global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Mass Production segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of 3D Printing Technology in Pharmaceutical include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, Craft Health, DiHeSys, Merck and AstraZeneca, etc. In terms of revenue, the global 3 largest players have a % market share of 3D Printing Technology in Pharmaceutical in 2021.
This report focuses on 3D Printing Technology in Pharmaceutical volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall 3D Printing Technology in Pharmaceutical market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the 3D Printing Technology in Pharmaceutical market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Material Extrusion
Binder Jetting
Powder Bed Fusion
VAT Photopolymerization
Segment by Application
Mass Production
Personalized Medicine
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Craft Health
DiHeSys
Merck
AstraZeneca
Frequently Asked Questions
Which product segment grabbed the largest share in the 3D Printing Technology in Pharmaceutical market?
How is the competitive scenario of the 3D Printing Technology in Pharmaceutical market?
Which are the key factors aiding the 3D Printing Technology in Pharmaceutical market growth?
Which are the prominent players in the 3D Printing Technology in Pharmaceutical market?
Which region holds the maximum share in the 3D Printing Technology in Pharmaceutical market?
What will be the CAGR of the 3D Printing Technology in Pharmaceutical market during the forecast period?
Which application segment emerged as the leading segment in the 3D Printing Technology in Pharmaceutical market?
What key trends are likely to emerge in the 3D Printing Technology in Pharmaceutical market in the coming years?
What will be the 3D Printing Technology in Pharmaceutical market size by 2028?
Which company held the largest share in the 3D Printing Technology in Pharmaceutical market?


Table of Contents

    1 3D Printing Technology in Pharmaceutical Market Overview

    • 1.1 Product Overview and Scope of 3D Printing Technology in Pharmaceutical
    • 1.2 3D Printing Technology in Pharmaceutical Segment by Type
      • 1.2.1 Global 3D Printing Technology in Pharmaceutical Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Material Extrusion
      • 1.2.3 Binder Jetting
      • 1.2.4 Powder Bed Fusion
      • 1.2.5 VAT Photopolymerization
    • 1.3 3D Printing Technology in Pharmaceutical Segment by Application
      • 1.3.1 Global 3D Printing Technology in Pharmaceutical Sales Comparison by Application: (2022-2028)
      • 1.3.2 Mass Production
      • 1.3.3 Personalized Medicine
    • 1.4 Global 3D Printing Technology in Pharmaceutical Market Size Estimates and Forecasts
      • 1.4.1 Global 3D Printing Technology in Pharmaceutical Revenue 2017-2028
      • 1.4.2 Global 3D Printing Technology in Pharmaceutical Sales 2017-2028
      • 1.4.3 3D Printing Technology in Pharmaceutical Market Size by Region: 2017 Versus 2021 Versus 2028

    2 3D Printing Technology in Pharmaceutical Market Competition by Manufacturers

    • 2.1 Global 3D Printing Technology in Pharmaceutical Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global 3D Printing Technology in Pharmaceutical Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global 3D Printing Technology in Pharmaceutical Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers 3D Printing Technology in Pharmaceutical Manufacturing Sites, Area Served, Product Type
    • 2.5 3D Printing Technology in Pharmaceutical Market Competitive Situation and Trends
      • 2.5.1 3D Printing Technology in Pharmaceutical Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest 3D Printing Technology in Pharmaceutical Players Market Share by Revenue
      • 2.5.3 Global 3D Printing Technology in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 3D Printing Technology in Pharmaceutical Retrospective Market Scenario by Region

    • 3.1 Global 3D Printing Technology in Pharmaceutical Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global 3D Printing Technology in Pharmaceutical Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America 3D Printing Technology in Pharmaceutical Market Facts & Figures by Country
      • 3.3.1 North America 3D Printing Technology in Pharmaceutical Sales by Country
      • 3.3.2 North America 3D Printing Technology in Pharmaceutical Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe 3D Printing Technology in Pharmaceutical Market Facts & Figures by Country
      • 3.4.1 Europe 3D Printing Technology in Pharmaceutical Sales by Country
      • 3.4.2 Europe 3D Printing Technology in Pharmaceutical Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific 3D Printing Technology in Pharmaceutical Market Facts & Figures by Region
      • 3.5.1 Asia Pacific 3D Printing Technology in Pharmaceutical Sales by Region
      • 3.5.2 Asia Pacific 3D Printing Technology in Pharmaceutical Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America 3D Printing Technology in Pharmaceutical Market Facts & Figures by Country
      • 3.6.1 Latin America 3D Printing Technology in Pharmaceutical Sales by Country
      • 3.6.2 Latin America 3D Printing Technology in Pharmaceutical Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
      • 3.6.6 Colombia
    • 3.7 Middle East and Africa 3D Printing Technology in Pharmaceutical Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa 3D Printing Technology in Pharmaceutical Sales by Country
      • 3.7.2 Middle East and Africa 3D Printing Technology in Pharmaceutical Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global 3D Printing Technology in Pharmaceutical Historic Market Analysis by Type

    • 4.1 Global 3D Printing Technology in Pharmaceutical Sales Market Share by Type (2017-2022)
    • 4.2 Global 3D Printing Technology in Pharmaceutical Revenue Market Share by Type (2017-2022)
    • 4.3 Global 3D Printing Technology in Pharmaceutical Price by Type (2017-2022)

    5 Global 3D Printing Technology in Pharmaceutical Historic Market Analysis by Application

    • 5.1 Global 3D Printing Technology in Pharmaceutical Sales Market Share by Application (2017-2022)
    • 5.2 Global 3D Printing Technology in Pharmaceutical Revenue Market Share by Application (2017-2022)
    • 5.3 Global 3D Printing Technology in Pharmaceutical Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Aprecia Pharmaceuticals
      • 6.1.1 Aprecia Pharmaceuticals Corporation Information
      • 6.1.2 Aprecia Pharmaceuticals Description and Business Overview
      • 6.1.3 Aprecia Pharmaceuticals 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Aprecia Pharmaceuticals 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.1.5 Aprecia Pharmaceuticals Recent Developments/Updates
    • 6.2 Triastek
      • 6.2.1 Triastek Corporation Information
      • 6.2.2 Triastek Description and Business Overview
      • 6.2.3 Triastek 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Triastek 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.2.5 Triastek Recent Developments/Updates
    • 6.3 FabRx
      • 6.3.1 FabRx Corporation Information
      • 6.3.2 FabRx Description and Business Overview
      • 6.3.3 FabRx 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 FabRx 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.3.5 FabRx Recent Developments/Updates
    • 6.4 Multiply Labs
      • 6.4.1 Multiply Labs Corporation Information
      • 6.4.2 Multiply Labs Description and Business Overview
      • 6.4.3 Multiply Labs 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Multiply Labs 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.4.5 Multiply Labs Recent Developments/Updates
    • 6.5 Craft Health
      • 6.5.1 Craft Health Corporation Information
      • 6.5.2 Craft Health Description and Business Overview
      • 6.5.3 Craft Health 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Craft Health 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.5.5 Craft Health Recent Developments/Updates
    • 6.6 DiHeSys
      • 6.6.1 DiHeSys Corporation Information
      • 6.6.2 DiHeSys Description and Business Overview
      • 6.6.3 DiHeSys 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 DiHeSys 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.6.5 DiHeSys Recent Developments/Updates
    • 6.7 Merck
      • 6.6.1 Merck Corporation Information
      • 6.6.2 Merck Description and Business Overview
      • 6.6.3 Merck 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Merck 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.7.5 Merck Recent Developments/Updates
    • 6.8 AstraZeneca
      • 6.8.1 AstraZeneca Corporation Information
      • 6.8.2 AstraZeneca Description and Business Overview
      • 6.8.3 AstraZeneca 3D Printing Technology in Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 AstraZeneca 3D Printing Technology in Pharmaceutical Product Portfolio
      • 6.8.5 AstraZeneca Recent Developments/Updates

    7 3D Printing Technology in Pharmaceutical Manufacturing Cost Analysis

    • 7.1 3D Printing Technology in Pharmaceutical Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of 3D Printing Technology in Pharmaceutical
    • 7.4 3D Printing Technology in Pharmaceutical Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 3D Printing Technology in Pharmaceutical Distributors List
    • 8.3 3D Printing Technology in Pharmaceutical Customers

    9 3D Printing Technology in Pharmaceutical Market Dynamics

    • 9.1 3D Printing Technology in Pharmaceutical Industry Trends
    • 9.2 3D Printing Technology in Pharmaceutical Market Drivers
    • 9.3 3D Printing Technology in Pharmaceutical Market Challenges
    • 9.4 3D Printing Technology in Pharmaceutical Market Restraints

    10 Global Market Forecast

    • 10.1 3D Printing Technology in Pharmaceutical Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of 3D Printing Technology in Pharmaceutical by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of 3D Printing Technology in Pharmaceutical by Type (2023-2028)
    • 10.2 3D Printing Technology in Pharmaceutical Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of 3D Printing Technology in Pharmaceutical by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of 3D Printing Technology in Pharmaceutical by Application (2023-2028)
    • 10.3 3D Printing Technology in Pharmaceutical Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of 3D Printing Technology in Pharmaceutical by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of 3D Printing Technology in Pharmaceutical by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:
      Get latest Market Research Reports on 3D Printing Technology in Pharmaceutical. Industry analysis & Market Report on 3D Printing Technology in Pharmaceutical is a syndicated market report, published as Global 3D Printing Technology in Pharmaceutical Market Research Report 2022. It is complete Research Study and Industry Analysis of 3D Printing Technology in Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,235.90
      4,471.80
      2,685.40
      5,370.80
      444,396.00
      888,792.00
      244,557.00
      489,114.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report